EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation

Carcinogenesis

Volumn 33, Issue 10, 2012, Pages 1919-1929

  Kiefel, Helena ^a   Bondong, Sandra ^a   Pfeifer, Marco ^a   Schirmer, Uwe ^a   Erbe Hoffmann, Natalie ^a   Schäfer, Heiner ^b   Sebens, Susanne ^b   Altevogt, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; EZRIN; FOCAL ADHESION KINASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN LINKED KINASE; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NERVE CELL ADHESION MOLECULE L1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BINDING SITE; BREAST CARCINOMA; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION;

ANTIGENS, CD29; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-1BETA; NEURAL CELL ADHESION MOLECULE L1; NF-KAPPA B; PANCREATIC NEOPLASMS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84867273359     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs220     Document Type: Article

References (55)

1. Grivennikov, S.I. et al. (2010) Immunity, inflammation, and cancer. Cell, 140, 883-899.
2. Christiansen, J.J. et al. (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res., 66, 8319-8326.
3. Polyak, K. et al. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer, 9, 265-273.
4. Cheng, G.Z. et al. (2007) Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res., 67, 1979-1987.
5. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
6. Arumugam, T. et al. (2009) Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res., 69, 5820-5828.
7. Thiery, J.P. et al. (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol., 7, 131-142.
8. Gavert, N. et al. (2008) Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol. Med., 14, 199-209.
9. Zavadil, J. et al. (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 24, 5764-5774.
10. Lo, H.W. et al. (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res., 67, 9066-9076.
11. Leong, K.G. et al. (2007) Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J. Exp. Med., 204, 2935-2948.
12. Huszar, M. et al. (2010) Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J. Pathol., 220, 551-561.
13. Geismann, C. et al. (2009) Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res., 69, 4517-4526.
14. Moos, M. et al. (1988) Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature, 334, 701-703.
15. Brummendorf, T. et al. (1998) Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. Curr. Opin. Neurobiol., 8, 87-97.
16. Schachner, M. (1997) Neural recognition molecules and synaptic plasticity. Curr. Opin. Cell Biol., 9, 627-634.
17. Schafer, M.K. et al. (2010) L1CAM malfunction in the nervous system and human carcinomas. Cell Mol. Life Sci., 67, 2425-2437.
18. Gavert, N. et al. (2008) L1-CAM in cancerous tissues. Expert Opin. Biol. Ther., 8, 1749-1757.
19. Schaefer, A.W. et al. (1999) Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J. Biol. Chem., 274, 37965-37973.
20. Silletti, S. et al. (2004) Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J. Biol. Chem., 279, 28880-28888.
21. Gavert, N. et al. (2005) L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J. Cell Biol., 168, 633-642.
22. Gast, D. et al. (2008) The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene, 27, 1281-1289.
23. Riedle, S. et al. (2009) Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity. Biochem. J., 420, 391-402.
24. Kiefel, H. et al. (2010) L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression. Oncogene, 29, 4766-4778.
25. Kiefel, H. et al. (2011) Linking L1CAM-mediated signaling to NF-kappaB activation. Trends Mol. Med., 17, 178-187.
26. Gavert, N. et al. (2010) Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J. Cell Sci., 123, 2135-2143.
27. Mechtersheimer, S. et al. (2001) Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J. Cell Biol., 155, 661-673.
28. Kalthoff, H. et al. (1993) p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene, 8, 289-298.
29. Sebens Muerkoster, S. et al. (2007) Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene, 26, 2759-2768.
30. Lemke, J. et al. (2010) TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5. J. Mol. Med., 88, 729-740.
31. Marme, F. et al. (2012) CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Res. Treat., 132, 819-831.
32. Gutwein, P. et al. (2000) Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J. Biol. Chem., 275, 15490-15497.
33. Issa, Y. et al. (2009) Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration. J. Mol. Med., 87, 99-112.
34. Pfeifer, M. et al. (2010) L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions. BMC Mol. Biol., 11, 64.
35. Bondong, B. et al. (2011) Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NFκB activation. Ann Oncol. 2012; 23(7):1795-802.
36. Brunner, G. et al. (1998) Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation. Exp. Cell Res., 239, 301-310.
37. Arlt, A. et al. (2003) Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene, 22, 3243-3251.
38. Muerkoster, S. et al. (2005) Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells. Cancer Res., 65, 1316-1324.
39. Bhowmick, N.A. et al. (2001) Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.J. Biol. Chem., 276, 46707-46713.
40. Mamuya, F.A. et al. (2012) aV integrins and TGF-β-induced EMT: a circle of regulation. J. Cell Mol. Med., 16, 445-455.
41. Guo, W. et al. (2004) Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol., 5, 816-826.
42. Legate, K.R. et al. (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat. Rev. Mol. Cell Biol., 7, 20-31.
43. Margadant, C. et al. (2010) Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep., 11, 97-105.
44. Gast, D. et al. (2005) L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int. J. Cancer, 115, 658-665.
45. Tischler, V. et al. (2011) L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol. Cancer, 10, 127.
46. Gast, D. et al. (2008) The RGD integrin binding site in human L1-CAM is important for nuclear signaling. Exp. Cell Res., 314, 2411-2418.
47. Stoeck, A. et al. (2007) L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol. Oncol., 104, 461-469.
48. Min, J.K. et al. (2010) L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin. Cancer Res., 16, 3571-3580.
49. Yang, M. et al. (2011) L1 stimulation of human glioma cell motility correlates with FAK activation. J. Neurooncol., 105, 27-44.
50. Guan, J.L. (2010) Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life, 62, 268-276.
51. Cheng, L. et al. (2005) L1-mediated branching is regulated by two ezrin-radixin-moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region. J. Neurosci., 25, 395-403.
52. Huber, M.A. et al. (2004) NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest., 114, 569-581.
53. Gavert, N. et al. (2007) Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res., 67, 7703-7712.
54. Meier, F. et al. (2006) The adhesion molecule L1 (CD171) promotes melanoma progression. Int. J. Cancer, 119, 549-555.
55. Thelen, K. et al. (2002) The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins. J. Neurosci., 22, 4918-4931.